Magnolia Medical Technologies, the Seattle diagnostics company whose Steripath device reduces false-positive blood culture results in sepsis testing, has committed to 9,751 square...
ByThe RegistryJuly 14, 2026Seattle’s life sciences vacancy rate surged 540 basis points year over year to 19 percent in the second quarter as new lab space...
ByThe RegistryJuly 9, 2026Seattle’s life sciences sector remains one of the most dynamic components of the city’s economy, even as overall investment levels adjust from the...
ByThe RegistryFebruary 5, 2025 
Signup for news and special announcements!
You have successfully joined our subscriber list.